Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-17-026974

Chief Executive Officer acquired 978,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2017-04-12 Grant or award : show line 1 in the form +978,000 1,794,789 D
Loading xslF345X03/doc4.xml…